Thank you for choosing to make a single donation.

With your help, ICR scientists can contiune to make significant breakthroughs, such as the discovery and development of the revolutionary prostate cancer drug abiraterone. This pioneering drug was made available on the NHS in 2012 and was first shown to be effective in men with advanced prostate cancer. It is now extending the lives of men around the world.